US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
ATE326458T1
(de)
*
|
2000-09-15 |
2006-06-15 |
Vertex Pharma |
Pyrazolverbindungen als protein-kinasehemmer
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
ZA200301701B
(en)
*
|
2000-09-15 |
2004-03-01 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors.
|
EP1698627A1
(en)
*
|
2000-09-15 |
2006-09-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
DK1353916T3
(da)
*
|
2000-12-21 |
2007-01-29 |
Vertex Pharma |
Pyrazolforbindelser der er egnede som proteinkinaseinhibitorer
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
EA007430B1
(ru)
|
2001-09-26 |
2006-10-27 |
Фармация Италия С.П.А. |
Производные аминоиндазола, активные в качестве ингибиторов киназ, способ их получения и содержащая их фармацевтическая композиция
|
SG159380A1
(en)
*
|
2002-02-06 |
2010-03-30 |
Vertex Pharma |
Heteroaryl compounds useful as inhibitors of gsk-3
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
CA2486101C
(en)
|
2002-05-17 |
2009-07-07 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
CN101037438A
(zh)
|
2002-08-02 |
2007-09-19 |
沃泰克斯药物股份有限公司 |
用作gsk-3的抑制剂的吡唑组合物
|
CA2502429A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Antiinflammation agents
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
WO2005056547A2
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
AU2006279376B2
(en)
|
2005-08-18 |
2011-04-14 |
Vertex Pharmaceuticals Incoporated |
Pyrazine kinase inhibitors
|
NZ594385A
(en)
*
|
2005-11-03 |
2013-02-22 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
WO2007121339A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Abbott Laboratories |
Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors
|
MX2009004807A
(es)
|
2006-11-02 |
2009-06-15 |
Vertex Pharma |
Aminopiridinas y aminopirimidinas utiles como inhibidores de proteina cinasa.
|
DE602007007985D1
(de)
|
2006-12-19 |
2010-09-02 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete aminopyrimidine
|
EP2134709A1
(en)
|
2007-03-09 |
2009-12-23 |
Vertex Pharmaceuticals, Inc. |
Aminopyridines useful as inhibitors of protein kinases
|
AU2008226466B2
(en)
|
2007-03-09 |
2013-06-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
JP5520057B2
(ja)
|
2007-03-09 |
2014-06-11 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
蛋白キナーゼの阻害剤として有用なアミノピリミジン
|
CN101679386A
(zh)
|
2007-04-13 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
AU2008247594A1
(en)
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
EP2152694A2
(en)
*
|
2007-05-02 |
2010-02-17 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
JP5572087B2
(ja)
*
|
2007-05-02 |
2014-08-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害として有用なアミノピリミジン
|
AU2008257044A1
(en)
*
|
2007-05-24 |
2008-12-04 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
EP2176261B1
(en)
*
|
2007-07-31 |
2012-12-19 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
JP2012501971A
(ja)
*
|
2008-09-03 |
2012-01-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶および共結晶を含む薬学的処方物
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
DK2890684T3
(en)
|
2012-07-24 |
2018-05-07 |
Bial Portela & Ca Sa |
URINARY COMPOUNDS AND THEIR USE AS ENZYMINE INHIBITORS
|
BR112015001769A2
(pt)
*
|
2012-07-27 |
2017-08-22 |
Bial Portela & Ca Sa |
Processo para a síntese de compostos de ureia substituída
|
JP6449277B2
(ja)
|
2013-07-24 |
2019-01-09 |
ビアル−ポルテラ エ コンパニア,ソシエダッド アノニマ |
イミダゾールカルボキサミドおよびfaah阻害剤としてのそれらの使用
|